Oculis Holding AG (OCSAW) Stock: Why It's Down Today
Updated Oct 19, 2026, 4:00 PM ET · closing price
- Closed at $2.40, -13.67% vs the prior close of $2.78.
- Volume 8.93K shares, 0.7x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
OCSAW slides 13.7% to $2.40. Closed at $2.40, -13.67% vs the prior close of $2.78. Day range $2.34–$3.25, opened at $9.91.
OCSAW daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — OCSAW slides 13.7% to $2.40
- Closed at $2.40, -13.67% vs the prior close of $2.78. Day range $2.34–$3.25, opened at $9.91.
- Volume was 8.93K shares, 0.7x its 50-day average of 12.03K.
- 52-week range $2.34–$3.53; today's close sits at 5% of that range, 32.0% below the 52-week high.
OCSAW bull case vs bear case (from the data)
- No clear positive signal in the price trend, filings or insider data right now.
- High volatility: average daily move of 13.7% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
OCSAW latest news & SEC filings
Every SEC filing by or about OCSAW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 10, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 6, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jun 25, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade OCSAW
- How much it moves: over the last 20 sessions the average daily move was 13.67% (largest 13.7%). That is a volatile stock.
- Liquidity: about 10.48K shares (≈$25.15K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.40 vs a range of $2.34–$3.53 (5% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 30, 2026; 6-K Aug 10, 2026; 6-K Aug 6, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
OCSAW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 9.91 | 3.25 | 2.34 | 2.40 | 8.93K |
| Oct 16, 2026 | 9.91 | 3.53 | 2.50 | 2.78 | 12.03K |
About Oculis Holding AG
Oculis Holding AG (OCSAW) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in ZUG, Switzerland. State of incorporation: Switzerland. Fiscal year ends December 31. SEC CIK 1953530.
OCSAW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
OCSAW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
OCSAW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)Novo Nordisk A S (NVO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on OCSAW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 19, 2026, 4:00 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.